The study of the efficacy and safety of Tonsilgon® N in the treatment of chronic pharyngitis

Abstract

Chronic pharyngitis is one of the most common diseases in ENT practice. [1] Experts have not yet come to a consensus on how to treat chronic pharyngitis. The search for combination drugs which are effective in the treatment of chronic pharyngitis is determined, first, by an attempt to prevent polypharmacy and complications caused by treatment, and, second, by the problem of antibiotic resistance. The role of medications with combined action, including the immunomodulating effect, cannot be overestimated. One of the most commonly used drugs today is Tonsilgon® N (Bionorica SE, Germany). [2]